MDNC — Medinotec Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Medinotec, fiscal year end - February 28th, USD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 1.04 | 1 |
| Cost of Revenue | ||
| Gross Profit | 0.455 | 0.582 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Total Operating Expenses | 1.23 | 1.46 |
| Operating Profit | -0.191 | -0.465 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -0.189 | -0.391 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -0.124 | -0.353 |
| Net Income Before Extraordinary Items | ||
| Net Income | -0.124 | -0.353 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | -0.124 | -0.353 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -0.011 | -0.03 |
| Dividends per Share |